Women’s Health Company to Expand

Jul 17, 2018

Cervical cancer if not caught early in the precancerous stage can be deadly. Approximately 250,000 women die each year around the world due to the disease, according to Scottish medical device firm DYSIS Medical. The company offers the Ultra colposcope, a noninvasive device used to screen for cervical cancer by allowing the detection and diagnosis of precancerous lesions on the cervix. According to DYSIS, the latest version of the Ultra colposcope incorporates several advances that have met important milestones. Most notably, the device is now recommended by the UK’s National Health Service. In addition, the results of a US clinical ...

Read More

Royal College welcomes global health leaders to Glasgow

Jun 5, 2018

Leadership in global health will be the first topic in a new series of President’s Leadership Lectures from the Royal College of Physicians and Surgeons of Glasgow. The event will be held on 5th June 2018 (6pm-7.30pm) at the College’s headquarters on 232-242 St. Vincent Street, Glasgow. The free lecture will be delivered by Professor John Meara and surgeon David McAdam, and will be the first in a series of public events run by the Royal College which aim to provide a public platform for some of the key issues facing medicine in the twenty-first century. Announcing the line-up, College ...

Read More

Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas

May 31, 2018

Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes Crystal Lake, Illinois and Madison, Aptar Pharma, a leading provider of innovative drug delivery systems, and Propeller Health, a leading digital therapeutics company, announced plans to collaborate on the launch of a comprehensive platform to develop digital medicines for multiple therapeutic areas and diseases. The digital medicine platform, spanning inhaled, injectable, nasal and dermal medicine delivery forms, will combine software and experiences with connected drug delivery devices to more effectively treat diseases and improve clinical outcomes for patients. Aptar Pharma ...

Read More

Franco-Quebecois Forum for Health Innovation (FFQIS): successful second edition strengthens international partnerships

May 17, 2018

With a focus on medical imaging, digital health, biomaterials and biomechanics, the event, promoting knowledge sharing and B2B meetings, took place on May 15 and 16 in Paris Medicen Paris Region, the French Alliance for Life Sciences and Health (Alliance française pour les sciences de la vie et de la santé – Aviesan), MEDTEQ and Polytechnique Montréal and TransMedTech, alongside several French and Quebecois partners, declared the second edition of the FFQIS a great success. In total, close to 150 participants from France and Quebec (Canada), as well as from other Francophone countries such as Belgium, Switzerland and Algeria, assembled at ...

Read More

CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company

May 9, 2018

CRF Health, the leading provider of patient-centered eSource for the life sciences industry, today announced that its electronic Clinical Outcome Assessment (eCOA) solutions have been selected for a significant insomnia trial by a European pharmaceutical company specializing in the discovery and development of small molecules. The landmark Phase III study involving 5,000 subjects across three continents collects key endpoint data made possible by CRF Health’s TrialMax® platform. CRF Health will be providing the eCOA solution (TrialMax Touch® and TrialMax Slate®) to all patients in the study for use on-site and via home-based devices, to record both patient and clinician facing ...

Read More